Literature DB >> 26379250

Correction: In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.

Blair R Anderson, David N Howell, Karen Soldano, Melanie E Garrett, Nicholas Katsanis, Marilyn J Telen, Erica E Davis, Allison E Ashley-Koch.   

Abstract

Entities:  

Year:  2015        PMID： 26379250      PMCID： PMC4574926          DOI： 10.1371/journal.pgen.1005459

Source DB:  PubMed          Journal:  PLoS Genet        ISSN： 1553-7390            Impact factor:   5.917


× No keyword cloud information.
The following information is missing from the Funding section: This study was supported by National Institutes of Health, P50 DK096415: to NK.
  1 in total

1.  In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.

Authors:  Blair R Anderson; David N Howell; Karen Soldano; Melanie E Garrett; Nicholas Katsanis; Marilyn J Telen; Erica E Davis; Allison E Ashley-Koch
Journal:  PLoS Genet       Date:  2015-07-06       Impact factor: 5.917
  1 in total
  3 in total

1.  Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.

Authors:  Julia Z Xu; Melanie E Garrett; Karen L Soldano; Sean T Chen; Clary B Clish; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2018-09-27       Impact factor: 10.047

Review 2.  The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.

Authors:  Parnaz Daneshpajouhnejad; Jeffrey B Kopp; Cheryl A Winkler; Avi Z Rosenberg
Journal:  Nat Rev Nephrol       Date:  2022-02-25       Impact factor: 42.439

3.  Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.

Authors:  Joanna Pazik; Monika Oldak; Dominika Oziębło; Dominika Dęborska Materkowska; Anna Sadowska; Jacek Malejczyk; Magdalena Durlik
Journal:  BMC Nephrol       Date:  2020-09-01       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.